메뉴 건너뛰기




Volumn 19, Issue 20, 2013, Pages 5788-5797

Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer

Author keywords

[No Author keywords available]

Indexed keywords

FANCONI ANEMIA GROUP A PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PEROXIREDOXIN 2; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PLATINUM DERIVATIVE; PROTEIN KINASE B; PROTEIN P53; TAXANE DERIVATIVE; TRANSCRIPTION FACTOR E2F1; VASCULOTROPIN A; VASCULOTROPIN B;

EID: 84886403668     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-1217     Document Type: Article
Times cited : (42)

References (36)
  • 1
    • 84886430163 scopus 로고    scopus 로고
    • Novel anti-angiogenic therapies in ovarian cancer
    • Kaye S, Brown R, Gabra H, Gore M, editor. New York: Springer
    • Hasan J, Jayson G. Novel anti-angiogenic therapies in ovarian cancer. In: Kaye S, Brown R, Gabra H, Gore M, editor. Emerging therapeutic targets in ovarian cacner. New York: Springer; 2011. p. 51-72.
    • (2011) Emerging Therapeutic Targets in Ovarian Cacner , pp. 51-72
    • Hasan, J.1    Jayson, G.2
  • 2
    • 0037862963 scopus 로고    scopus 로고
    • Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2. 2 trial
    • Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet 2003;361:2099-106.
    • (2003) Lancet , vol.361 , pp. 2099-2106
    • Parmar, M.K.1    Ledermann, J.A.2    Colombo, N.3    Du Bois, A.4    Delaloye, J.F.5    Kristensen, G.B.6
  • 3
    • 0038576158 scopus 로고    scopus 로고
    • The power and the promise of DNA methylation markers
    • Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-66.
    • (2003) Nat Rev Cancer , vol.3 , pp. 253-266
    • Laird, P.W.1
  • 4
    • 84871923658 scopus 로고    scopus 로고
    • Epigenetics makes its mark on women-specific cancers-an opportunity to redefine oncological approaches?
    • Widschwendter M, Jones A, Teschendorff AE. Epigenetics makes its mark on women-specific cancers-an opportunity to redefine oncological approaches? Gynecol Oncol 2013;128:134-43.
    • (2013) Gynecol Oncol , vol.128 , pp. 134-143
    • Widschwendter, M.1    Jones, A.2    Teschendorff, A.E.3
  • 5
    • 84869876903 scopus 로고    scopus 로고
    • Detection of cancer-specific epigenomic changes in biofluids: Powerful tools in biomarker discovery and application
    • Nogueira da Costa A, Herceg Z. Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application. Mol Oncol 2012;6:704-15.
    • (2012) Mol Oncol , vol.6 , pp. 704-715
    • Nogueira Da Costa, A.1    Herceg, Z.2
  • 9
    • 79955477996 scopus 로고    scopus 로고
    • Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
    • O'Malley DM, Richardson DL, Rheaume PS, Salani R, Eisenhauer EL, McCann GA, et al. Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer. Gynecol Oncol 2011;121:269-72.
    • (2011) Gynecol Oncol , vol.121 , pp. 269-272
    • O'Malley, D.M.1    Richardson, D.L.2    Rheaume, P.S.3    Salani, R.4    Eisenhauer, E.L.5    McCann, G.A.6
  • 10
    • 84861736119 scopus 로고    scopus 로고
    • OCEANS: A randomized, double-blind, placebocontrolled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    • Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, et al. OCEANS: a randomized, double-blind, placebocontrolled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol 2012; 30:2039-45
    • (2012) J Clin Oncol , vol.30 , pp. 2039-2045
    • Aghajanian, C.1    Blank, S.V.2    Goff, B.A.3    Judson, P.L.4    Teneriello, M.G.5    Husain, A.6
  • 11
    • 79959218200 scopus 로고    scopus 로고
    • Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival
    • Dai W, Teodoridis JM, Zeller C, Graham J, Hersey J, Flanagan JM, et al. Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival. Clin Cancer Res 2011;17:4052-62.
    • (2011) Clin Cancer Res , vol.17 , pp. 4052-4062
    • Dai, W.1    Teodoridis, J.M.2    Zeller, C.3    Graham, J.4    Hersey, J.5    Flanagan, J.M.6
  • 12
    • 0033535612 scopus 로고    scopus 로고
    • A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
    • Strathdee G, MacKean MJ, Illand M, Brown R. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene 1999;18:2335-41.
    • (1999) Oncogene , vol.18 , pp. 2335-2341
    • Strathdee, G.1    Mackean, M.J.2    Illand, M.3    Brown, R.4
  • 14
    • 0031981857 scopus 로고    scopus 로고
    • Dependence of McrBC cleavage on distance between recognition elements
    • Stewart FJ, Raleigh EA. Dependence of McrBC cleavage on distance between recognition elements. Biol Chem 1998;379:611-6.
    • (1998) Biol Chem , vol.379 , pp. 611-616
    • Stewart, F.J.1    Raleigh, E.A.2
  • 15
    • 0026634757 scopus 로고
    • McrBC: A multisubunit GTP-dependent restriction endonuclease
    • Sutherland E, Coe L, Raleigh EA. McrBC: a multisubunit GTP-dependent restriction endonuclease. J Mol Biol 1992;225:327-48.
    • (1992) J Mol Biol , vol.225 , pp. 327-348
    • Sutherland, E.1    Coe, L.2    Raleigh, E.A.3
  • 16
    • 79959838081 scopus 로고    scopus 로고
    • Integrated genomic analyses of ovarian carcinoma
    • Cancer Genome Atlas Research N
    • Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-15.
    • (2011) Nature , vol.474 , pp. 609-615
  • 17
    • 0001677717 scopus 로고
    • Controlling the false discovery rate: A practical and powerful approach to multiple testing
    • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 1995;57:289-300.
    • (1995) J R Stat Soc ser B (Methodological) , vol.57 , pp. 289-300
    • Benjamini, Y.1    Hochberg, Y.2
  • 19
    • 0034213974 scopus 로고    scopus 로고
    • Clinical characteristics of clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy
    • Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y, Kita T, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000;88:2584-9.
    • (2000) Cancer , vol.88 , pp. 2584-2589
    • Sugiyama, T.1    Kamura, T.2    Kigawa, J.3    Terakawa, N.4    Kikuchi, Y.5    Kita, T.6
  • 20
    • 0036498788 scopus 로고    scopus 로고
    • Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
    • Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59.
    • (2002) J Clin Oncol , vol.20 , pp. 1248-1259
    • Bristow, R.E.1    Tomacruz, R.S.2    Armstrong, D.K.3    Trimble, E.L.4    Montz, F.J.5
  • 21
    • 33847065486 scopus 로고    scopus 로고
    • The epigenomics of cancer
    • Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128: 683-92.
    • (2007) Cell , vol.128 , pp. 683-692
    • Jones, P.A.1    Baylin, S.B.2
  • 23
    • 67650401865 scopus 로고    scopus 로고
    • DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage
    • Watts GS, Futscher BW, Holtan N, Degeest K, Domann FE, Rose SL. DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage. BMC Med Genomics 2008;1:47.
    • (2008) BMC Med Genomics , vol.1 , pp. 47
    • Watts, G.S.1    Futscher, B.W.2    Holtan, N.3    Degeest, K.4    Domann, F.E.5    Rose, S.L.6
  • 24
    • 3042774430 scopus 로고    scopus 로고
    • The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients
    • Gifford G, Paul J, Vasey PA, Kaye SB, Brown R. The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients. Clin Cancer Res 2004;10: 4420-6.
    • (2004) Clin Cancer Res , vol.10 , pp. 4420-4426
    • Gifford, G.1    Paul, J.2    Vasey, P.A.3    Kaye, S.B.4    Brown, R.5
  • 25
    • 84867743287 scopus 로고    scopus 로고
    • Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
    • Zeller C, Dai W, Steele NL, Siddiq A, Walley AJ, Wilhelm-Benartzi CS, et al. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling. Oncogene 2012;31:4567-76.
    • (2012) Oncogene , vol.31 , pp. 4567-4576
    • Zeller, C.1    Dai, W.2    Steele, N.L.3    Siddiq, A.4    Walley, A.J.5    Wilhelm-Benartzi, C.S.6
  • 26
    • 78649537524 scopus 로고    scopus 로고
    • Biomarkers to predict the clinical efficacy of bevacizumab in cancer
    • Jubb AM, Harris AL. Biomarkers to predict the clinical efficacy of bevacizumab in cancer. Lancet Oncol 2010;11:1172-83.
    • (2010) Lancet Oncol , vol.11 , pp. 1172-1183
    • Jubb, A.M.1    Harris, A.L.2
  • 27
    • 84865141645 scopus 로고    scopus 로고
    • VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression
    • Cao Y, E G, Wang E, Pal K, Dutta SK, Bar-Sagi D, et al. VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. Cancer Res 2012;72: 3912-8.
    • (2012) Cancer Res , vol.72 , pp. 3912-3918
    • Cao, Y.1    Eo, G.2    Wang, E.3    Pal, K.4    Dutta, S.K.5    Bar-Sagi, D.6
  • 29
    • 78649655419 scopus 로고    scopus 로고
    • Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis
    • Albrecht I, Kopfstein L, Strittmatter K, Schomber T, Falkevall A, Hagberg CE, et al. Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis. PLoS ONE 2010;5:e14109.
    • (2010) PLoS ONE , vol.5
    • Albrecht, I.1    Kopfstein, L.2    Strittmatter, K.3    Schomber, T.4    Falkevall, A.5    Hagberg, C.E.6
  • 30
    • 40549090548 scopus 로고    scopus 로고
    • VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats
    • Li Y, Zhang F, Nagai N, Tang Z, Zhang S, Scotney P, et al. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest 2008;118:913-23.
    • (2008) J Clin Invest , vol.118 , pp. 913-923
    • Li, Y.1    Zhang, F.2    Nagai, N.3    Tang, Z.4    Zhang, S.5    Scotney, P.6
  • 31
    • 60549100360 scopus 로고    scopus 로고
    • Integral role of transcription factor 8 in the negative regulation of tumor angiogenesis
    • Inuzuka T, Tsuda M, Tanaka S, Kawaguchi H, Higashi Y, Ohba Y. Integral role of transcription factor 8 in the negative regulation of tumor angiogenesis. Cancer Res 2009;69:1678-84.
    • (2009) Cancer Res , vol.69 , pp. 1678-1684
    • Inuzuka, T.1    Tsuda, M.2    Tanaka, S.3    Kawaguchi, H.4    Higashi, Y.5    Ohba, Y.6
  • 32
    • 77956945067 scopus 로고    scopus 로고
    • BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma
    • Ibrahim N, He L, Leong CO, Xing D, Karlan BY, Swisher EM, et al. BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma. Cancer Res 2010;70:7155-65.
    • (2010) Cancer Res , vol.70 , pp. 7155-7165
    • Ibrahim, N.1    He, L.2    Leong, C.O.3    Xing, D.4    Karlan, B.Y.5    Swisher, E.M.6
  • 33
    • 0035129906 scopus 로고    scopus 로고
    • From angiogenesis to lymphangiogenesis
    • Plate K. From angiogenesis to lymphangiogenesis. Nat Med 2001;7: 151-2.
    • (2001) Nat Med , vol.7 , pp. 151-152
    • Plate, K.1
  • 34
    • 84873267168 scopus 로고    scopus 로고
    • Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer
    • Cheng D, Liang B, Li Y. Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer. PLoS ONE 2013;8:e55309.
    • (2013) PLoS ONE , vol.8
    • Cheng, D.1    Liang, B.2    Li, Y.3
  • 35
    • 20944436359 scopus 로고    scopus 로고
    • Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas
    • Ueda M, Hung YC, Terai Y, Kanda K, Kanemura M, Futakuchi H, et al. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Clin Cancer Res 2005;11:3225-32.
    • (2005) Clin Cancer Res , vol.11 , pp. 3225-3232
    • Ueda, M.1    Hung, Y.C.2    Terai, Y.3    Kanda, K.4    Kanemura, M.5    Futakuchi, H.6
  • 36
    • 69249103708 scopus 로고    scopus 로고
    • Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75
    • Cohen B, Addadi Y, Sapoznik S, Meir G, Kalchenko V, Harmelin A, et al. Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75. Neoplasia 2009;11:921-33.
    • (2009) Neoplasia , vol.11 , pp. 921-933
    • Cohen, B.1    Addadi, Y.2    Sapoznik, S.3    Meir, G.4    Kalchenko, V.5    Harmelin, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.